Cambridge, UK, 16 August 2006: BioProgress plc (‘BioProgress’ or the ‘Company’) (AIM: BPRG; NASDAQ: BPRG), the speciality pharma and healthcare company, today announces that it has developed a novel enteric tablet-coating system, EntWrap™. In addition, the Company announces that the first TabWrap™ tablet-coating machine is due to be placed into a cGMP pharmaceutical tablet manufacturing facility within the UK in Q4 2006 for a series of initial validation tests.
